https://www.drugdeliverybusiness.com/insulet-investor-day-omnipod-6-2027/
Dec 2, 2025 - Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.
next geninsuletlaunch
https://www.prweek.com/article/1942457/insulet-hires-mercks-cristal-downing-chief-corporate-affairs-officer
Insulet hires Merck's Cristal Downing as chief corporate affairs officer. From PR Week
corporate affairsinsulethiresmerckcristal
https://www.drugdeliverybusiness.com/insulet-q3-2025-increases-guidance-growth/
Nov 6, 2025 - Insulet (Nasdaq:PODD) shares rose slightly before hours today on third-quarter results that landed well ahead of the consensus forecast.
insuletincreasesguidancebeatssales
https://www.greatplacetowork.co.uk/certified-company/1559037
Discover why Insulet is Great Place To Work Certified. Explore their workplace culture and find out what employees say about what it's like to work at Insulet.
workinginsuletgreatplaceuk
https://www.drugdeliverybusiness.com/insulet-ceo-ashley-mcevoy-omnipod-6-innovation-roadmap/
Nov 20, 2025 - Insulet (Nasdaq:PODD) today hosted its Investor Day event, led by CEO Ashley McEvoy, laying out the future for the insulin pump maker.
insuletceoashleytalksinnovation
https://www.statnews.com/2024/12/05/insulet-wins-trade-secret-case-against-eoflow-insulin-pump-maker/
Dec 6, 2024 - Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, which Medtronic was looking to acquire in 2023.
trade secretsinsuletwinscasekorean